THE USE OF HEMALOG-D FOR MONITORING THE STEM-CELL POPULATION IN PATIENTS TREATED FOR ACUTE MYELOID-LEUKEMIA

被引：0
|
作者：
WINKEL, P [1 ]
OLESEN, T [1 ]
机构：
[1] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK
来源：
JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY | 1980年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：648 / 648
页数：1
相关论文
共 50 条
  • [41] THE ROLES OF STEM-CELL SELF-RENEWAL AND AUTOCRINE GROWTH-FACTOR PRODUCTION IN THE BIOLOGY OF MYELOID-LEUKEMIA
    METCALF, D
    CANCER RESEARCH, 1989, 49 (09) : 2305 - 2311
  • [42] Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation
    Meloni, G
    Proia, A
    Guerrisi, V
    Cordone, I
    De Cuia, R
    Fenu, S
    Mauro, FR
    Pescarmona, E
    Reato, G
    Mandelli, F
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1493 - 1495
  • [43] AUTOLOGOUS STEM-CELL GRAFTING IN ACUTE MYELOID-LEUKEMIA - TECHNICAL APPROACH OF MARROW INCUBATION INVITRO WITH PHARMACOLOGICAL AGENTS (PREREQUISITE FOR CLINICAL-APPLICATIONS)
    HERVE, P
    TAMAYO, E
    PETERS, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1983, 53 (04) : 683 - 685
  • [44] Role of KIR Genotype in Acute Myeloid Leukemia Treated with Stem Cell Transplant
    Odstrcil, Maria
    Binder, Fernando
    Molina, Lucia
    Larriba, Julian
    Tambutti, Monica
    Ferini, Gonzalo
    Bendek, Georgina
    Arbelbide, Jorge
    Basquiera, Ana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S304 - S304
  • [45] Disparities in the Upfront Use of Hematopoietic Stem Cell Transplant Among Patients with Acute Myeloid Leukemia
    Mehmood, Tahir
    Bartley, Adam C.
    Hashmi, Shahrukh K.
    Go, Ronald S.
    BLOOD, 2016, 128 (22)
  • [46] Is it time for erythropoietin use in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients?
    Helbig, Grzegorz
    Kyrcz-Krzemien, Slawomira
    CHINESE CLINICAL ONCOLOGY, 2012, 1 (02)
  • [47] Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia
    Ciftciler, Rafiye
    Demiroglu, Haluk
    Buyukasik, Yahya
    Aladag, Elifcan
    Aksu, Salih
    Haznedaroglu, Ibrahim C.
    Sayinalp, Nilgun
    Ozcebe, Osman
    Malkan, Umit Yavuz
    Goker, Hakan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (03): : 177 - 182
  • [48] CELL-MEDIATED INHIBITION OF GRANULOPOIESIS INVITRO IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN REMISSION
    SALLERFORS, B
    OLOFSSON, T
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 42 (02) : 164 - 172
  • [49] RELATION BETWEEN AGE AND BLAST CELL-DIFFERENTIATION IN ACUTE MYELOID-LEUKEMIA PATIENTS
    HASSAN, HT
    REES, JKH
    ONCOLOGY, 1990, 47 (05) : 439 - 442
  • [50] Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
    Lim, ZiYi
    Brand, Ronald
    Martino, Rodrigo
    van Biezen, Anja
    Finke, Juergen
    Bacigalupo, Andrea
    Beelen, Dietrich
    Devergie, Agnes
    Alessandrino, Emilio
    Willemze, Roel
    Ruutu, Tapani
    Boogaerts, Marc
    Falda, Michele
    Jouet, Jean-Pierre
    Niederwieser, Dietger
    Kroger, Nicolaus
    Mufti, Ghulam J.
    De Witte, Theo M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 405 - 411
12345